Inventages Venture Capital Investment focuses on funding Health Tech and Biotech companies at the Series B stage, with investments ranging from $500k to $10M. They support businesses like Phagenesis and manage $1.5 billion in committed capital. Operating globally from offices in Nassau, Geneva, Auckland, and London, Inventages contributes to the growth of management teams and companies through their experience and network.
